Actualités et événements
EMA Primary endpoint qualification of SV95C
SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95 th Centile (SV95C) for Duchenne Muscular Dystrophy.
Link to the press release here:
